WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR April 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: APRIL ISSUE PUBLISHED

    APRIL 2024 Issue has been successfully launched on APRIL 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

CHARACTERISTICS OF RENAL CELL CARCINOMA IN PATIENTS ADMITTED TO GHAZI AL-HARIRI SURGICAL SPECIALTY TEACHING HOSPITAL, BAGHDAD-IRAQ 2020-2022

*Reem Yousif Ali Ghalib Yassin and Dr. Nadia Hameed

ABSTRACT

Background: RCC is the most prevalent kidney cancer. It causes 90% of kidney cancers and 2% of adult cancers. The 2020 Iraqi Cancer Registry reported 200 new kidney cancer cases, 129 males and 71 females, with an occurrence rate of 2.97/100000 male population and 1.68/100000 female population. This research examined the epidemiology, histopathology, and staging of renal cell carcinoma patients at Ghazy AL-Hariri Surgical Specialty Teaching Hospital and identified characteristics related with advanced staging and grading. Method: A cross sectional study was conducted at Ghazy AL-Hariri Surgical Specialty Teaching Hospital, Medical City Health Directorate during the period from January, 2020- July 2022. All records of patients with renal cell carcinoma available during the study period were reviewed and a data collection form was prepared to collect the available data from patients’ pathological records. Results: The present research comprised 100 renal cell carcinoma cases, 65 (65%) of which were male, roughly 2:1. Their mean age was 53.4 ± 10.8 years, ranging from 30 to 80. Radical nephrectomy was done on 88.0% of right kidney tumours. Most tumours were lower pole (35.0%), conventional renal cell CA/clear cell type (76.0%), and unifocal (96.0%). 8 individuals had sarcomatoid characteristics, 38 had kidney-limited tumours, and 29 had perinephric fat infiltration. Grading showed that 49.0% of patients were G2, 24.0% G3, and 62.0% pT3. 91% had no lympho-vascular invasion and all had clear surgical margins. The tumour size ranges from 1.5-20 cm with a mean of 6.7 ± 3.3 cm SD. Patients with pT2 and pT3 had larger tumours than those with pT1 (ANOVA, P

[Full Text Article] [Download Certificate]